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Zyxin’s Role in the Hippo PathwayThe Hippo pathway is a conserved regulator of organ growth that computes
information from the cellular microenvironment. A new study examines the role
of the Hippo pathway protein Zyxin and finds that it antagonises Expanded to
modulate F-actin and organ size.Kieran F. Harvey
Cellular signalling pathways commonly
transmit information from the
extracellular environment to the
nucleus to modulate transcription and
elicit a biological response. The Hippo
pathway is one of the most recently
identified and intensely studied
signalling pathways. Unlike most
pathways, which transmit information
downstream of diffusible extracellular
ligands that bind to transmembrane
receptor proteins, the Hippo pathway
appears predominantly to convey
information about the ‘cellular
neighbourhood’ of tissues [1–3]. Hippo
signalling has been shown to be
influenced by G-protein-coupled
receptors [4], which are regulated by
diffusible ligands, but is also controlled
by transmembrane proteins that form
ligand–receptor pairs between
neighbouring cells (e.g. the Fat and
Dachsous cadherins, Crumbs and
Echinoid) [5]. The Hippo pathway also
responds to key cell biological
properties, such as cell polarity and cell
adhesion [1–3]. In addition, this
pathway is sensitive to mechanical
properties of cells and tissues, and it
has been touted as a key integrator of
tissue mechanics, in the context of
both organ size control and
tumorigenesis [6]. In this role the Hippo
pathway is thought to be controlled by
the tensile state of the actin
cytoskeleton [2,6].
Two of the best-studied upstream
regulators of the Hippo pathway are Fatand Expanded. Fat engages in
bidirectional signalling with its ligand
Dachsous and signals via several
proteins, including the atypical
myosin Dachs and the casein
kinase Discs overgrown [7,8].
Expanded forms complexes with
multiple Hippo pathway proteins,
including the upstream regulators
Merlin and Kibra and the core pathway
members Warts, Hippo, Salvador and
Yorkie [9–11]. Expanded can repress
Yorkie by direct binding and also by
activating the kinase Warts, which
phosphorylates and inhibits Yorkie
[9–11]. Despite rapid advances in the
past decade or so, many aspects of
Hippo signalling are still shrouded in
uncertainty.
In a study published in this issue of
Current Biology, Gaspar et al. [12]
address the role of Zyxin, a protein
that has been independently linked
to both Hippo signalling and
mechanotransduction, and suggest
that Zyxin might present a nexus
between the two. Zyxin possesses a
triple LIM domain that has been shown
to mediate its association with focal
adhesions and actin fibres. It also binds
to the F-actin polymerisation factors
Enabled and VASP in both Drosophila
melanogaster and mammalian cultured
cells [13,14]. Zyxin is recruited to
F-actin that has been compromised by
mechanical force and is proposed to
induce actin fibre repair at least in part
by recruiting Enabled/VASP [15]. Zyxin
also controls tissue growth via the
Hippo pathway [16]. Based largelyon RNA interference studies, Zyxin
had been proposed to function
downstream of the Fat branch of the
Hippo pathway, but independently
of Expanded [16]. In particular,
biochemical experiments showed
that Zyxin bound to both Dachs
and the key kinase Warts and that
Zyxin functions with Dachs to limit
Warts levels via an as yet unknown
mechanism [16].
The genomic localisation of
D. melanogaster zyxin (on the relatively
small and less genetically tractable
fourth chromosome) has hindered the
ability to study this gene using
traditional loss-of-function alleles.
Gaspar et al. [12] have now overcome
this challenge by using genome
editing to generate null zyxin
mutant flies, which allowed them to
reappraise its role in Hippo signalling
and tissue growth. Based on several
phenotypes of zyxin null tissue,
and the fact that zyxin overexpression
strongly rescued phenotypes
caused by expanded overexpression,
they conclude that Zyxin has a major
role in antagonising Expanded.
Key data supporting their claims
include the demonstration that zyxin
loss strongly suppressed imaginal
disc overgrowth and defects in
eye differentiation associated with
expanded loss but not fat loss,
while zyxin overexpression more
robustly counteracted growth
retardation induced by expanded
than that induced by fat. Perhaps
most compelling is the finding that
zyxin loss brought expanded, but not
fat, mutant flies back to life [12].
It is difficult to fully reconcile the
seemingly different results presented
in this study and that from Rauskolb
et al. [16], but it should be recognised
that, whilst RNA interference has
revolutionised the study of gene
function in many organisms, including
D. melanogaster, it has many
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R231limitations. Two possible issues that
could cloud zyxin RNA interference
phenotypes are off-target effects
and hypomorphism. It is formally
possible that Zyxin functions
downstream of both Fat and
Expanded, however. Genetic epistasis
studies can be misleading, especially
when used to study interconnected
upstream regulators of a signalling
network that ultimately converge
on the same downstream proteins.
Therefore, further biochemical and
cell biological analyses are necessary
to fully define Zyxin’s role in the Hippo
pathway.
How does Zyxin function
downstream of Expanded? Three
main possibilities exist, based on the
known roles of Expanded. Firstly,
Zyxin could regulate the activity of
the Hippo pathway core kinase
cassette. This is possible but was not
favoured as a major function of Zyxin
by Gaspar et al. [12], as zyxin loss only
partially suppressed overgrowth
resulting from hippo loss, whilst
Warts-dependent phosphorylation of
Yorkie was unaltered in fly tissues
overexpressing zyxin [12]. Given that
Expanded binds to Hippo, Warts
and Yorkie and regulates their
phosphorylation [9–11], and that Zyxin
has been reported to bind to Warts and
influence Warts levels [16], this could
be examined further. For example, it
would be ideal to be able to monitor
even subtle changes in Warts
activity/levels in organs that
overexpress or lack zyxin.
Secondly, Zyxin could interfere with
Expanded’s ability to bind directly to
Yorkie and repress it. This possibility
was ruled out, however, by the finding
that zyxin loss strongly suppressed
phenotypes associated with tissues
that were nullizygous for
expanded [12].
Thirdly, Zyxin could regulate Yorkie
activity by modulating the actin
cytoskeleton. Evidence for this
possibility was presented by Gaspar
et al. [12], who found that both Zyxin
and Expanded influence each other’s
ability to modulate F-actin [12]. Given
known links between actin and Hippo,
they proposed that Expanded and
Zyxin regulate Yorkie-mediated organ
growth by antagonising each other’s
influence on F-actin. This assertionwas
supported by functional links between
Zyxin and Enabled, a regulator of
F-actin polymerisation. The
Enabled-binding domain of Zyxin wasrequired for it to suppress
Expanded-induced growth retardation
and to cooperate with Enabled to
induce tissue overgrowth. Gaspar et al.
[12] also showed that actin capping
proteins, which block F-actin growth
and are known to limit Yorkie-driven
tissue growth [17,18], antagonised
Zyxin’s ability to stimulate tissue
growth.
Thus, Gaspar et al. [12] favour a
scenario whereby Zyxin modulates
Yorkie independent of Warts, primarily
by promoting F-actin assembly, a
function that is counteracted by
Expanded [12]. A related mechanism
has been proposed for the regulation
of Yorkie’s mammalian orthologues
YAP and TAZ. In human cultured
cells, F-actin assembly promoted
YAP/TAZ activity independent
of the Warts orthologues LATS1
and LATS2 [19]. Furthermore, in
uveal melanoma cells, hyperactive
G proteins (Gq and G11) were found
to stimulate YAP activity via F-actin
polymerisation, but independent of
LATS1 and LATS2 [20]. Therefore,
actin-dependent regulation of
Yorkie/YAP/TAZ, independent of
Warts/LATS1/LATS2, appears to be a
conserved regulatory mechanism
important for both normal and
neoplastic tissue growth. Important
future questions on the role of Zyxin
in Hippo-pathway-dependent tissue
growth include: when and where
does Zyxin function in growing
tissues? Is Zyxin regulated by
mechanical properties of cells in
growing and/or regenerating organs?
And how does actin regulate
Yorkie/YAP/TAZ independent of
Warts/LATS1/LATS2?References
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